Glossary

A genetic testing company specializing in multi-gene pathway analysis — examining how an individual's genetic variants affect key biological pathways including metabolism, inflammation, hormones, and nutrients. Used at SPOKEmed to personalize clinical protocols.

A blood test measuring the percentage of hemoglobin coated with glucose over the past 2 to 3 months, used to diagnose and monitor blood sugar regulation, prediabetes, and type 2 diabetes.

Dark, velvety patches of skin that appear in body folds — typically the back of the neck, underarms, and groin — caused by elevated insulin levels. A visible clinical indicator of insulin resistance that is frequently misattributed to poor hygiene or dismissed as cosmetic.

A clinical specialty — primarily organized through A4M (the American Academy of Anti-Aging Medicine) — focused on the biological mechanisms of aging and evidence-based interventions designed to extend functional healthspan. Distinct from cosmetic anti-aging treatments in that it addresses the internal biology driving the aging process.

A synthetic peptide fragment derived from the C-terminal region of growth hormone, studied in clinical trials for its potential metabolic effects — particularly fat reduction — without the growth-promoting or blood sugar-elevating effects of full growth hormone.

A protein that forms the outer shell of all atherogenic (artery-clogging) lipoprotein particles — including LDL, VLDL, and Lp(a). ApoB is a more accurate predictor of cardiovascular disease risk than LDL-cholesterol alone.

A category of diseases in which the immune system mistakenly attacks the body's own healthy tissues — producing chronic inflammation, organ damage, and systemic dysfunction across a wide range of affected systems.

Hormones that are chemically identical in molecular structure to the hormones naturally produced by the human body. Used in hormone replacement therapy for perimenopause and menopause.

A measurable biological indicator — in blood, urine, stool, or tissue — that provides objective, quantifiable information about a patient's health status, disease risk, or treatment response. The difference between normal-range biomarkers and optimal-range biomarkers is central to SPOKEmed's clinical model.

A voluntary credential in medicine and advanced practice indicating that a clinician has met education, training, and examination standards set by a recognized specialty board — above and beyond what is required for licensure.

The proportion of fat mass, lean muscle mass, bone, and water that make up total body weight. A more accurate health indicator than weight or BMI alone.

A synthetic peptide derived from a protein found in human gastric juice, studied in preclinical and early clinical research for its potential tissue repair, anti-inflammatory, and gut-protective properties. Regulatory status is evolving.

A state of cognitive impairment characterized by difficulty concentrating, memory lapses, mental sluggishness, and reduced mental clarity — commonly experienced during perimenopause and menopause as a result of hormonal, metabolic, and sleep-related changes.

A synthetic analogue of growth hormone-releasing hormone (GHRH) that stimulates pituitary GH secretion with extended duration due to a drug affinity complex modification. Frequently combined with ipamorelin for synergistic growth hormone support. Available only through compounding pharmacies — regulatory availability subject to ongoing FDA review.

Hydrolyzed collagen protein broken down into short amino acid chains (primarily glycine, proline, and hydroxyproline) that are absorbed and used by the body to support connective tissue, skin, joint, bone, and gut health.

A licensed pharmacy that prepares customized medications not commercially available in standard formulations — including personalized doses, alternative delivery routes, or medications during manufacturer shortages.

A standard blood test measuring 14 markers including blood glucose, kidney function, liver enzymes, and electrolytes. A foundational but limited metabolic assessment that SPOKEmed expands with additional targeted markers.

The body's primary stress hormone, produced by the adrenal glands. When chronically elevated, cortisol promotes abdominal fat storage, impairs insulin sensitivity, disrupts sleep, and suppresses immune and hormonal function.

The combined structural and functional health of the gastrointestinal tract — including the gut lining, digestive enzyme systems, microbiome balance, and intestinal barrier — that together enable proper digestion, nutrient absorption, and protection against systemic inflammation. Often referred to in patient conversation as 'gut healing.'

A comprehensive urine-based hormone test that measures sex hormones, adrenal hormones, and their metabolites — providing a far more detailed picture of hormonal health than a standard blood draw.

The primary female sex hormone, produced mainly by the ovaries, that regulates the reproductive cycle and plays critical roles in bone health, cardiovascular function, brain health, metabolism, skin, and mood.

The conscientious integration of the best available clinical research with individual patient values and clinical expertise to make medical decisions — ensuring treatments are grounded in data, not tradition, anecdote, or financial incentive.

The persistent, intrusive mental preoccupation with food — constant thoughts about what to eat, when to eat, and cravings — driven by dysregulated hunger hormones and metabolic imbalance, not lack of willpower.

Non-allergic, non-IgE-mediated adverse reactions to specific foods that produce delayed and varied symptoms — including bloating, fatigue, brain fog, joint pain, skin issues, and headaches — driven by immune, enzymatic, or gut microbiome mechanisms.

A patient-centered medical approach that identifies and addresses the root causes of disease — using a systems-biology framework that considers genetics, environment, lifestyle, and the interconnected nature of biological systems — rather than managing isolated symptoms.

A hormone produced primarily in the stomach that stimulates appetite and promotes fat storage. Known as the hunger hormone, ghrelin rises before meals and spikes with sleep deprivation and caloric restriction.

A comprehensive stool DNA analysis test that quantifies gut bacteria, identifies pathogens and parasites, measures markers of intestinal inflammation and immune function, and assesses intestinal permeability. Used by SPOKEmed as a primary gut health diagnostic tool.

A naturally occurring gut hormone that regulates blood sugar, slows digestion, and reduces appetite. Pharmaceutical GLP-1 receptor agonists are used clinically to support significant, sustained weight loss.

A compound — including certain peptides and small molecules — that stimulates the pituitary gland to produce and release growth hormone through endogenous signaling pathways, rather than directly administering exogenous growth hormone.

The vast and complex community of trillions of microorganisms — including bacteria, fungi, viruses, and archaea — residing primarily in the large intestine. The gut microbiome plays foundational roles in metabolism, immunity, hormone regulation, mental health, and inflammation.

An autoimmune condition in which the immune system attacks the thyroid gland, gradually impairing its ability to produce thyroid hormone. The most common cause of hypothyroidism in the United States.

A structured, collaborative process in which a trained health coach supports patients in translating medical recommendations into sustainable daily behaviors — covering nutrition, physical activity, sleep, stress management, and hydration.

A blood or urine test measuring circulating hormone levels — typically including sex hormones, thyroid hormones, adrenal hormones, and/or pituitary markers — used to evaluate hormonal balance and identify deficiencies or excesses.

The clinical use of hormones — typically estrogen, progesterone, and sometimes testosterone — to supplement declining hormone levels during perimenopause and menopause, reducing symptoms and supporting long-term health.

Sudden episodes of intense body heat, flushing, and sweating caused by hormonal fluctuations during perimenopause and menopause. The most recognized symptom of the menopausal transition.

A functional gastrointestinal disorder characterized by recurring abdominal pain, bloating, and changes in bowel habits — including diarrhea, constipation, or alternating between both — in the absence of identifiable structural disease.

A condition in which the body's cells respond poorly to insulin, forcing the pancreas to overproduce it — leading to elevated blood sugar, increased fat storage, weight gain, and heightened metabolic disease risk.

A practice of medicine that combines conventional medical care with evidence-based complementary and lifestyle approaches — treating the whole person including physical, mental, nutritional, and lifestyle factors — rather than focusing exclusively on pharmacological intervention.

A selective growth hormone-releasing peptide (GHRP) that stimulates pituitary GH secretion without significantly elevating cortisol, prolactin, or ACTH — its selectivity profile making it clinically preferred over earlier-generation GHRPs for patients with cortisol dysregulation, which is extremely common in perimenopausal and menopausal women.

A condition in which the tight junctions of the intestinal lining become compromised, allowing incompletely digested food particles, bacterial components, and toxins to pass into the bloodstream — triggering immune activation, inflammation, and systemic health consequences.

A hormone produced by fat cells that signals fullness and satiety to the brain. In leptin resistance — common in obesity and metabolic dysfunction — this signal fails, leaving the brain in a perpetual state of perceived starvation.

A blood test measuring cholesterol and triglycerides — including total cholesterol, LDL-C, HDL-C, and triglycerides — used to evaluate cardiovascular risk. A standard lipid panel is enhanced with ApoB for more accurate particle-based risk assessment.

A clinical field focused on extending the healthy, functional lifespan — delaying or preventing age-related disease and decline through proactive, biomarker-guided interventions targeting the biological mechanisms of aging.

Reduced sexual desire or interest, often with hormonal, psychological, relational, and physical contributing factors. In midlife women, low libido frequently has identifiable and treatable hormonal causes.

The point in time marking 12 consecutive months without a menstrual period, signaling the permanent end of ovarian reproductive function. It is diagnosed retrospectively and typically occurs between ages 45 and 55.

A credential awarded by The Menopause Society (formerly NAMS — North American Menopause Society) to healthcare providers who demonstrate advanced knowledge and competency in evidence-based menopause care.

A state in which one or more of the body's metabolic systems — blood sugar regulation, fat metabolism, inflammation, or hormone signaling — are operating outside of healthy ranges, increasing disease risk and impairing daily function.

A state in which the body's five core metabolic markers — blood sugar, blood pressure, triglycerides, HDL cholesterol, and waist circumference — are all functioning within healthy ranges without medication.

A set of measurable blood-based indicators — including glucose, insulin, lipids, inflammatory proteins, and related compounds — that collectively characterize the state of a patient's metabolic health and risk for metabolic disease.

An imbalance in the gut microbiome — characterized by reduced diversity, overgrowth of harmful or opportunistic organisms, and depletion of beneficial bacteria — that disrupts normal gut function and contributes to systemic health problems.

The national certifying organization for Physician Assistants in the United States. NCCPA administers the board examination required for the PA-C designation and requires ongoing recertification — ensuring every certified PA maintains current clinical competency throughout their career. Patients can verify any PA's certification status at verify.nccpa.net.

Episodes of excessive sweating during sleep caused primarily by nocturnal hot flashes during perimenopause and menopause. Night sweats disrupt sleep architecture and have compounding effects on metabolic health, mood, and hormonal regulation.

The process by which the digestive system breaks down food and absorbs vitamins, minerals, macronutrients, and other compounds through the intestinal wall into the bloodstream. Impaired absorption leads to nutrient deficiencies even with adequate dietary intake.

A recognized medical specialty focused on the evaluation, treatment, and long-term management of obesity as a chronic disease — distinct from general advice about diet and exercise.

A complex hormonal disorder affecting women of reproductive age, characterized by irregular periods, elevated androgen levels, and often polycystic ovaries — with significant metabolic implications including insulin resistance and elevated diabetes risk.

The clinical use of short chains of amino acids (peptides) that act as biological signaling molecules — targeting specific receptors and pathways to support tissue repair, hormonal signaling, metabolic function, immune regulation, and other physiological processes.

The transitional phase before menopause — typically lasting 4 to 10 years — during which estrogen, progesterone, and testosterone levels fluctuate and decline, producing a wide range of physical, metabolic, cognitive, and emotional symptoms.

A stimulant-based prescription appetite suppressant approved for short-term weight loss. One of the most frequently prescribed weight loss medications in the US — and one patients frequently ask about when considering medical weight loss options at SPOKEmed.

A nationally certified advanced practice provider who has completed an accredited Physician Assistant master's-level program and passed the Physician Assistant National Certifying Examination (PANCE). PA-Cs practice medicine across all specialties under defined collaborative agreements.

Non-digestible dietary compounds — primarily specific fibers and resistant starches — that selectively feed and stimulate the growth of beneficial bacteria in the gut microbiome.

A medical approach that tailors prevention, diagnosis, and treatment to the individual patient's unique biology, genetics, lifestyle, and clinical data — rather than applying population-averaged, one-size-fits-all protocols.

Live microorganisms — primarily bacteria and yeasts — that, when consumed in adequate amounts, confer health benefits to the host by supporting and restoring gut microbiome balance.

A female sex hormone produced primarily by the corpus luteum after ovulation. It plays critical roles in the menstrual cycle, pregnancy, sleep quality, mood regulation, and protection of the uterine lining against estrogen's proliferative effects.

An FDA-approved peptide medication (bremelanotide, brand name Vyleesi) for hypoactive sexual desire disorder (HSDD) in premenopausal women. It activates melanocortin receptors in the brain to enhance sexual desire through a central — not hormonal — mechanism.

A condition in which stomach contents — including acid — flow back into the esophagus, causing symptoms such as heartburn, regurgitation, chronic cough, and throat irritation. Often driven by impaired lower esophageal sphincter function and in some cases by low stomach acid.

A clinical philosophy and practice methodology focused on identifying and treating the underlying biological causes driving a patient's symptoms or conditions, rather than suppressing symptoms without investigating their origin.

A once-weekly GLP-1 receptor agonist used for chronic weight management and blood sugar control. Available under the brand names Wegovy (weight loss) and Ozempic (diabetes).

A synthetic peptide analogue of the first 29 amino acids of natural growth hormone-releasing hormone (GHRH), which stimulates the pituitary to produce growth hormone. The only GHRH analogue with prior FDA approval history for pediatric GH deficiency.

Metabolites produced when gut bacteria ferment dietary fiber — particularly butyrate, propionate, and acetate — that serve as the primary energy source for intestinal cells, reduce gut inflammation, strengthen the gut lining, improve insulin sensitivity, and regulate appetite.

The clinical and behavioral practice of improving sleep quality, duration, and architecture to support hormonal regulation, metabolic health, cognitive function, immune competence, and weight management.

The clinical and behavioral practice of managing the physiological stress response — including cortisol regulation, HPA axis function, and nervous system balance — to reduce the downstream metabolic, hormonal, and immune consequences of chronic stress.

A state of chronic, low-grade immune activation throughout the body — distinct from acute inflammation in response to injury or infection — that silently promotes metabolic disease, hormonal dysfunction, cardiovascular risk, autoimmune conditions, and accelerated aging.

SPOKEmed's clinical service offering peptide therapies prescribed individually — based on comprehensive patient evaluation, clinical indication, and current regulatory context — as part of an integrated precision medicine approach to metabolic health, hormonal optimization, and longevity.

The delivery of healthcare services remotely through video, phone, or digital communication platforms — allowing patients to access clinical consultations, prescriptions, lab reviews, and ongoing care without in-person visits.

A sex hormone present in women at lower levels than in men, playing important roles in libido, energy, mood, muscle strength, bone density, and cognitive function. Testosterone declines with age and hormonal transition in women.

The collective capacity of the thyroid gland to produce, convert, and deploy thyroid hormones — primarily T4 (thyroxine) and T3 (triiodothyronine) — which regulate metabolism, energy, mood, weight, temperature, and virtually every cell in the body.

A dual GLP-1 and GIP receptor agonist medication approved for chronic weight management. It activates two metabolic pathways simultaneously, producing greater average weight loss than single-mechanism GLP-1 agents.

A condition caused by declining estrogen during and after menopause that causes thinning, drying, and inflammation of vaginal and urinary tissues. It is now more broadly termed Genitourinary Syndrome of Menopause (GSM).

Fat stored deep within the abdominal cavity, surrounding internal organs. Unlike subcutaneous fat under the skin, visceral fat is metabolically active and strongly linked to cardiovascular disease, insulin resistance, and systemic inflammation.